Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
QSYMIA Risk Evaluation and Mitigation Strategy (REMS) Because of the teratogenic risk associated with QSYMIA therapy, QSYMIA is available through a limited program under the REMS
An integrated single-cell reference atlas of the human endometrium
The area under the curve (AUC), continuous net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were performed to compare the discriminative ability of CCL28 on the traditional CTO risk model
They serve as an alternative to cash payment when insurance coverage is unavailable or insufficient
Sweat is not plotting against your melanocytes
US$ 22.48
US$ 20.87
US$ 23.17
US$ 25.51
US$ 25.61
US$ 25.79
US$ 23.29
